Skip to main content

111, Inc.

corporate_fare Company Profile

111, Inc.

YI·NASDAQ·Trade & Services·CIK 0001738906

1 Medicine Marketplace operates as a digital healthcare platform in China, connecting patients with medicine and healthcare services. The company was founded in 2010 with the launch of 1 Medicine Marketplace, an online retail pharmacy in China. Today, it provides pharmaceutical products and medical services directly to hundreds of millions of consumers through its online retail pharmacy network. Additionally, 1 Pharmacy serves as an online wholesale pharmacy, offering a selection of pharmaceutical products to pharmacies, clinics, and hospitals. The platform provides a range of healthcare services, including consultations, diagnosis, and medication delivery. It also offers tools for upstream pharmaceutical manufacturers and downstream pharmacies. Consumers can access medical advice and consultation services from home, while businesses can utilize digital services for increased efficiency. The company aims to improve the efficiency, transparency, and quality of drug distribution by reconstructing the healthcare industry's value chain and traditional pharmaceutical distribution system through digital technology, business intelligence, a self-operated central warehouse, and third-party distribution.

111, Inc. (NASDAQ:YI) is a publicly traded company in the Trade & Services sector. Wiseek monitors YI SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • 111, Inc. Reports Widening Q1 Loss and Significant Cash Burn Amid Strategic Transition
  • Auditor Issues Going Concern Warning Amidst Financial Losses and Significant Redemption Obligations
  • 111, Inc. Achieves Q4 Operating Profitability, Positive Cash Flow Amid Strategic Shift

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
¥12.56B CNY
Net Income
-¥22.52M CNY
Diluted EPS
-¥0.38 CNY
Op. Cash Flow
¥119.14M CNY
Free Cash Flow
¥114.69M CNY
Gross Profit
¥723.41M CNY
Operating Income
-¥2.38M CNY
Cash & Equivalents
¥510.97M CNY
Total Debt
¥187.63M CNY
Debt / Equity
-0.27×
Net Margin
-0.2%
Shares Outstanding
174.03M sh
Source: 20-F · filed 2026-04-30 · accession 0001104659-26-052002

Insider Transactions

YI files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with Y →
$4.76 -0.02% today
52-week range · as of 2026-06-04 $2.48 – $11.17
Market cap
$41.99M
Volume
19.7K (1.0× avg)
3-mo avg 19.9K
Live data · 2026-06-07 18:53 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed YI - Latest Insights

YI
Jun 04, 2026, 6:54 AM EDT
Filing Type: 6-K
Importance Score:
9
111, Inc. Reports Widening Q1 Loss and Significant Cash Burn Amid Strategic Transition
Price at Filing: $5.44
Real-time Price: $4.76 info
Change: -$0.680 (-13%) info
Market Cap: $41.993M info
Sentiment: Negative
View Wiseek Article
YI
Apr 30, 2026, 6:04 AM EDT
Filing Type: 20-F
Importance Score:
9
Auditor Issues Going Concern Warning Amidst Financial Losses and Significant Redemption Obligations
Price at Filing: $6.81
Real-time Price: $4.76 info
Change: -$2.05 (-30%) info
Market Cap: $41.993M info
Sentiment: Negative
View Wiseek Article
YI
Apr 09, 2026, 3:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
111, Inc. Achieves Q4 Operating Profitability, Positive Cash Flow Amid Strategic Shift
Price at Filing: $6.22
Real-time Price: $4.76 info
Change: -$1.46 (-23%) info
Market Cap: $41.993M info
Sentiment: Positive
View Wiseek Article